Kelsey-Seybold Clinic Revenue and Competitors

Houston, TX USA

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • Kelsey-Seybold Clinic's estimated annual revenue is currently $300M per year.(i)
  • Kelsey-Seybold Clinic's estimated revenue per employee is $824,176

Employee Data

  • Kelsey-Seybold Clinic has 364 Employees.(i)

Kelsey-Seybold Clinic's People

NameTitleEmail/Phone
1
Chief SurgeryReveal Email/Phone
2
Chief UrologyReveal Email/Phone
3
Chief Cardiology Reveal Email/Phone
4
Chief RadiologyReveal Email/Phone
5
Chief OphthalmologyReveal Email/Phone
6
Chief RheumatologyReveal Email/Phone
7
Chief AudiologyReveal Email/Phone
8
Chief Ear, Nose & ThroatReveal Email/Phone
9
Chief DermatologyReveal Email/Phone
10
Chief Ophthalmology/OptometryReveal Email/Phone

What Is Kelsey-Seybold Clinic?

Kelsey-Seybold Clinic, Houston’s largest and most renowned private multi-specialty physician group, was founded by Dr. Mavis Kelsey in 1949. Dr. Kelsey began with one office in the Texas Medical Center and a vision of creating Houston’s premiere medical practice.

keywords:N/A

N/A

Total Funding

364

Number of Employees

$300M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Kelsey-Seybold Clinic News

2022-04-19 - Kelsey-Seybold breaks ground on new Fairfield clinic

Officials with Kelsey-Seybold and the Cy-Fair Houston Chamber of Commerce gathered April 14 to break ground on the health care system's new...

2022-04-17 - Kelsey-Seybold breaks ground on 24,220-square-foot Fairfield clinic

Shown here, from left to right, Leslie Martone, Cy-Fair Houston Chamber of Commerce president; Caroline Okemwa, clinic administrator IV, Kelsey-...

2022-04-06 - Optum continues buying spree and scoops up Houston-based ...

With more than 500 physicians, Kelsey-Seybold Clinic operates multi-specialty care centers, a cancer center, a women's health center, two ambulatory surgery...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$54.8M3657%N/A
#2
$123.2M3659%N/A
#3
$147.3M3677%N/A
#4
$112.7M368-4%N/A
#5
$75M36828%N/A